Published in
American College of Physicians, Annals of Internal Medicine, 1(175), p. W4, 2022
DOI: 10.7326/l21-0708
American College of Physicians, Annals of Internal Medicine, 1(175), p. W3, 2022
DOI: 10.7326/l21-0707
American College of Physicians, Annals of Internal Medicine, 1(175), p. W3-W4, 2022
DOI: 10.7326/l21-0706
Links
- American College of Physicians
- American College of Physicians
- American College of Physicians
- ORCID
- American College of Physicians
- American College of Physicians
Tools
Sodium–Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists and the Risk for Cardiovascular Outcomes in Routine Care Patients With Diabetes Across Categories of Cardiovascular Disease
Journal article published in 2021 by
Sebastian Schneeweiss 
,
Deborah J. Wexler ,
Ajinkya Pawar,
Mei Qiu,
Elisabetta Patorno,
Lurit Bepo,
Phyo T. Htoo ,
Robert J. Glynn,
Lily G. Bessette ,
Anil N. Makam,
Kristyn Chin,
Brendan M. Everett ,
Seoyoung C. Kim ,
Oanh Kieu Nguyen
,
Deborah J. Wexler ,
Ajinkya Pawar,
Mei Qiu,
Elisabetta Patorno,
Lurit Bepo,
Phyo T. Htoo ,
Robert J. Glynn,
Lily G. Bessette ,
Anil N. Makam,
Kristyn Chin,
Brendan M. Everett ,
Seoyoung C. Kim ,
Oanh Kieu Nguyen
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Postprint:
archiving forbidden
Published version:
archiving forbidden
Data provided by 